COLCHICINE | A211519 | ZYDUS PHARMACEUTICALS USA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
TAKEDA PHARMACEUTICALS U.S.A., INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al 17 patentsANDA 211519colchicine, USP | D.N.J. | 2018-03-28 | Terminated 2018-10-25 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.1287
per ea
Lowest NADAC/Unit
$0.1287
per ea
Brand NDCs
0
Generic NDCs
4
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 16714003901COLCHICINE 0.6 MG TABLET | $0.1287 | EA | Generic | — | 2026-06-17 |
| 16714003902COLCHICINE 0.6 MG TABLET | $0.1287 | EA | Generic | — | 2026-06-17 |
| 70710135101COLCHICINE 0.6 MG TABLET | $0.1287 | EA | Generic | — | 2026-06-17 |
| 70710135103COLCHICINE 0.6 MG TABLET | $0.1287 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.